Aberrant upregulation of PBX3 has been observed in various cancers, including in acute myeloid leukemia [17] and in solid tumors, such as breast cancer [18], lung cancer [19], HCC [20], and colorectal cancer [21]. The gene discussed is PBX3; the disease is hepatocellular carcinoma.